Browse > Article
http://dx.doi.org/10.4047/jkap.2021.59.3.314

Osseointegration of dental implant in the mandible with diffuse sclerosing osteomyelitis: Report of a rare case  

Kang, Hyeon-Goo (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
Ko, Kyung-Ho (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
Huh, Yoon-Hyuk (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
Cho, Lee-Ra (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
Park, Chan-Jin (Department of Prosthodontics & Research Institute of Oral Science, College of Dentistry, Gangneung-Wonju National University)
Publication Information
The Journal of Korean Academy of Prosthodontics / v.59, no.3, 2021 , pp. 314-318 More about this Journal
Abstract
There are very few reports of the restoration of tooth loss using dental implants in patients with diffuse sclerosing osteomyelitis (DSO). Because the patients with DSO have unfavorable bone quality for osseointegration of dental implants, additional considerations such as surgical trauma, infection control, and an extended healing period are essential when placing dental implants. The purpose of this study is to report on the success of osseointegration of a dental implant in the patient with DSO.
Keywords
Dental implant; Diffuse sclerosing osteomyelitis; Healing period; Osseointegration;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jacobsson S. Diffuse sclerosing ostemyelitis of the mandible. Acta Otolaryngol Suppl 1979;360:61-3.
2 Neville B, Damm DD, Allen C, Bouquot J. Oral and maxillofacial pathology. 3rd Ed. Philadelphia; Saunders; 2008. p. 144-7.
3 Montonen M, Kalso E, Pylkkaren L, Lindstrorm BM, Lindqvist C. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg 2001;30:313-7.   DOI
4 Urade M, Noguchi K, Takaoka K, Moridera K, Kishimoto H. Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e9-12.
5 Otto S, Burian E, Troeltzsch M, Kaeppler G, Ehrenfeld M. Denosumab as a potential treatment alternative for patients suffering from diffuse sclerosing osteomyelitis of the mandible-A rapid communication. J Craniomaxillofac Surg 2018;46:534-7.   DOI
6 Shuren SL. The use of implant therapy in diffuse sclerosing osteomyelitis. J Oral Implantol 1994;20:60-2.
7 van Merkesteyn JP, Groot RH, Bras J, McCarroll RS, Bakker DJ. Diffuse sclerosing osteomyelitis of the mandible: a new concept of its etiology. Oral Surg Oral Med Oral Pathol 1990;70:414-9.   DOI
8 Kniha K, Heussen N, Weber E, Mohlhenrich SC, Holzle F, Modabber A. Temperature threshold values of bone necrosis for thermo-explantation of dental implants-a systematic review on preclinical in vivo research. Materials (Basel) 2020;13:3461.   DOI
9 Kuijpers SC, de Jong E, Hamdy NA, van Merkesteyn JP. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates. J Craniomaxillofac Surg 2011;39:65-8.   DOI